A detailed history of Geode Capital Management, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 988,171 shares of ALLK stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
988,171
Previous 907,408 8.9%
Holding current value
$1.25 Million
Previous $907,000 29.22%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.54 - $0.92 $43,612 - $74,301
80,763 Added 8.9%
988,171 $642,000
Q2 2024

Aug 09, 2024

SELL
$1.0 - $1.45 $722,413 - $1.05 Million
-722,413 Reduced 44.32%
907,408 $907,000
Q1 2024

May 13, 2024

BUY
$1.02 - $3.23 $40,502 - $128,256
39,708 Added 2.5%
1,629,821 $2.05 Million
Q4 2023

Feb 13, 2024

BUY
$1.72 - $3.18 $168,876 - $312,225
98,184 Added 6.58%
1,590,113 $4.34 Million
Q3 2023

Nov 13, 2023

BUY
$2.13 - $5.55 $153,628 - $400,299
72,126 Added 5.08%
1,491,929 $3.39 Million
Q2 2023

Aug 11, 2023

BUY
$3.6 - $5.25 $2.39 Million - $3.49 Million
664,221 Added 87.91%
1,419,803 $6.19 Million
Q1 2023

May 15, 2023

BUY
$4.3 - $8.27 $117,261 - $225,522
27,270 Added 3.74%
755,582 $3.36 Million
Q4 2022

Feb 13, 2023

BUY
$5.66 - $8.42 $670,806 - $997,913
118,517 Added 19.44%
728,312 $6.13 Million
Q3 2022

Nov 14, 2022

BUY
$3.02 - $6.12 $889,136 - $1.8 Million
294,416 Added 93.35%
609,795 $3.73 Million
Q2 2022

Aug 12, 2022

SELL
$2.6 - $6.14 $551,036 - $1.3 Million
-211,937 Reduced 40.19%
315,379 $987,000
Q1 2022

May 13, 2022

SELL
$5.08 - $9.81 $784,418 - $1.51 Million
-154,413 Reduced 22.65%
527,316 $3.01 Million
Q4 2021

Feb 11, 2022

BUY
$8.55 - $111.89 $689,232 - $9.02 Million
80,612 Added 13.41%
681,729 $6.67 Million
Q3 2021

Nov 12, 2021

BUY
$76.53 - $110.43 $1.01 Million - $1.45 Million
13,139 Added 2.23%
601,117 $63.6 Million
Q2 2021

Aug 13, 2021

BUY
$85.37 - $114.1 $7.11 Million - $9.51 Million
83,327 Added 16.51%
587,978 $50.2 Million
Q1 2021

May 12, 2021

BUY
$109.73 - $153.66 $4.08 Million - $5.72 Million
37,222 Added 7.96%
504,651 $57.9 Million
Q4 2020

Feb 12, 2021

BUY
$79.58 - $152.45 $5.76 Million - $11 Million
72,360 Added 18.32%
467,429 $65.4 Million
Q3 2020

Nov 13, 2020

BUY
$66.43 - $90.99 $105,357 - $144,310
1,586 Added 0.4%
395,069 $32.2 Million
Q2 2020

Aug 13, 2020

BUY
$44.04 - $80.69 $1.78 Million - $3.26 Million
40,431 Added 11.45%
393,483 $28.3 Million
Q1 2020

May 14, 2020

BUY
$44.49 - $93.39 $1.06 Million - $2.23 Million
23,848 Added 7.24%
353,052 $15.7 Million
Q4 2019

Feb 13, 2020

BUY
$66.49 - $137.73 $1.02 Million - $2.12 Million
15,360 Added 4.89%
329,204 $31.4 Million
Q3 2019

Nov 12, 2019

BUY
$31.0 - $89.73 $4.23 Million - $12.2 Million
136,404 Added 76.87%
313,844 $24.7 Million
Q2 2019

Aug 14, 2019

BUY
$36.0 - $44.73 $412,596 - $512,650
11,461 Added 6.91%
177,440 $7.69 Million
Q1 2019

May 14, 2019

BUY
$33.79 - $51.99 $1.45 Million - $2.23 Million
42,938 Added 34.9%
165,979 $6.72 Million
Q4 2018

Feb 13, 2019

SELL
$31.59 - $62.65 $66,654 - $132,191
-2,110 Reduced 1.69%
123,041 $6.43 Million
Q3 2018

Nov 13, 2018

BUY
$31.25 - $47.64 $3.91 Million - $5.96 Million
125,151 New
125,151 $5.63 Million

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $108M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.